Skip to main content
Equibles

NBTX · Nanobiotix S.A. · Financials

Track NBTX — free

Use NBTX with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research NBTX.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$25.39 -0.36 (-1.40%)
Rebalance outlook locked
Market Cap
$1.70B
Shares
50.92M
Volume · Oct 5 149.78K Avg daily vol (3M) 148.09K

Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.

Pull these statements through the financial statements API or MCP →
Revenue
32.59M +553.2%
FY2025 Revenue FY2018–FY2025
Net Income
-23.96M +64.8%
FY2025 Net Income FY2018–FY2025
Operating Margin
-33.19%
FY2025 Operating Margin FY2018–FY2025
Diluted EPS
-0.50 +65.3%
FY2025 Diluted EPS FY2018–FY2025
Operating Cash Flow
-33.42M -70.9%
FY2025 Operating Cash Flow FY2018–FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Income Statement Balance Sheet Cash Flow All Metrics
Annual Quarterly
Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
EUR 32.59M -7.19M 36.21M 4.78M 2.65M 2.51M 2.54M 3.48M
EUR 23.12M 40.54M 38.4M 32.64M 30.38M 24.33M 30.41M 20.89M
EUR 1.61M 1.62M 1.52M 1.5M 1.52M 1.58M 1.48M 529K
EUR -10.82M -68.39M -26.78M -46.7M -52.58M -36.43M -46.78M -30.07M
EUR 15.23M 7.49M 14.8M 13.86M 780K -2.65M 4.97M 1.45M
EUR -23.96M -68.13M -39.7M -57.04M -47M -33.59M -50.92M -30.35M
EUR 3000 101K 120K 10K 5000 9000 3000 0
EUR -23.96M -68.13M -39.7M -57.04M -47.06M -33.59M -50.92M -30.35M
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.

Key facts CIK 1760854 CUSIP 63009J107 Visit website Investor relations